Dr Mercola supporting LDN (again)

[Guest guest]

From: jaynelcrocker

Sent: Thursday, February 25, 2010 7:33 AM

low dose naltrexone , ldn_users

Subject: [LDN_Users] Dr Mercola supporting LDN (again)

Please read the attached link (you'll need to scroll down to see his comments http://www.mmshealthyforlife.com/?p=2162 Lots of other helpful information in this too.

However, there are a few other newer treatments that are worth looking into as well, especially low-dose Naltrexone (LDN), along with alpha lipoic acid.

Low-Dose Naltrexone

Naltrexone (generic name) is a pharmacologically active opioid antagonist, conventionally used to treat drug- and alcohol addiction -- normally at doses of 50mg to 300mg. As such, it's been an FDA-approved drug for over two decades.

However, researchers have found that at very low dosages (3 to 4.5 mg), naltrexone has immunomodulating properties that may be able to successfully treat cancer malignancies and a wide range of autoimmune diseases like rheumatoid arthritis, multiple sclerosis, Parkinson's, fibromyalgia, and Crohn's disease, just to name a few.

Dr. Bert Berkson is an expert on this regimen. For more information about his findings and successes using this combination, please review this previous article.

Jayne Crocker

www.LDNNow.com

Important! Please sign our LDN petition to the European Parliament by clicking here

tel: +44 (0) 7877 492 669

Dr Steele MBE, talking about LDN

LDNNow, a patient and friend led organisation (so not a charity) with no funding and no affiliation to any company or organisation, but rather a group of concerned individuals focussed on improving the health of those who suffer from the many diseases and conditions that LDN treats.

[Guest guest]

[LDN_Users] Dr Mercola supporting LDN (again)

Please read the attached link (you'll need to scroll down to see his

comments http://www.mmshealthyforlife.com/?p=2162 Lots of other helpful

information in this too.

However, there are a few other newer treatments that are worth looking into

as well, especially low-dose Naltrexone (LDN), along with alpha lipoic acid.

1. Low-Dose Naltrexone

Naltrexone (generic name) is a pharmacologically active opioid antagonist,

conventionally used to treat drug- and alcohol addiction -- normally at

doses of 50mg to 300mg. As such, it's been an FDA-approved drug for over two

decades.

However, researchers have found that at very low dosages (3 to 4.5 mg),

naltrexone has immunomodulating properties that may be able to successfully

treat cancer malignancies and a wide range of autoimmune diseases like

rheumatoid arthritis, multiple sclerosis, Parkinson's, fibromyalgia, and

Crohn's disease, just to name a few.

Dr. Bert Berkson is an expert on this regimen. For more information about

his findings and successes using this combination, please review

<http://articles.mercola.com/sites/articles/archive/2009/05/16/This-Antioxid

ant-Can-Smash-Insulin-Resistance-and-Autoimmune-Disease.aspx> this previous

article.

Jayne Crocker

www.LDNNow.com

<http://www.ipetitions.com/petition/ldnnow/> Important! Please sign our

LDN petition to the European Parliament by clicking here

tel: +44 (0) 7877 492 669

<

Dr Steele MBE, talking

about LDN

LDNNow, a patient and friend led organisation (so not a charity) with no

funding and no affiliation to any company or organisation, but rather a

group of concerned individuals focussed on improving the health of those who

suffer from the many diseases and conditions that LDN treats.

[Guest guest]

Please read the attached link (you'll need to scroll down to see his comments http://www.mmshealthyforlife.com/?p=2162 Lots of other helpful information in this too.

However, there are a few other newer treatments that are worth looking into as well, especially low-dose Naltrexone (LDN), along with alpha lipoic acid.

Low-Dose Naltrexone

Naltrexone (generic name) is a pharmacologically active opioid antagonist, conventionally used to treat drug- and alcohol addiction -- normally at doses of 50mg to 300mg. As such, it's been an FDA-approved drug for over two decades.

However, researchers have found that at very low dosages (3 to 4.5 mg), naltrexone has immunomodulating properties that may be able to successfully treat cancer malignancies and a wide range of autoimmune diseases like rheumatoid arthritis, multiple sclerosis, Parkinson's, fibromyalgia, and Crohn's disease, just to name a few.

Dr. Bert Berkson is an expert on this regimen. For more information about his findings and successes using this combination, please review this previous article.

Jayne Crocker

www.LDNNow.com

Important! Please sign our LDN petition to the European Parliament by clicking here

tel: +44 (0) 7877 492 669

Dr Steele MBE, talking about LDN

LDNNow, a patient and friend led organisation (so not a charity) with no funding and no affiliation to any company or organisation, but rather a group of concerned individuals focussed on improving the health of those who suffer from the many diseases and conditions that LDN treats.